Effect of percutaneous coronary intervention for chronic total occlusion on diastolic atrioventricular coupling in ST-elevation myocardial infarction patients

Percutaneous coronary intervention (PCI) for chronic total occlusion (CTO) did not improve left ventricular systolic function. The left atrioventricular coupling index (LACI), derived from cardiovascular magnetic resonance (CMR), reflects diastolic atrioventricular coupling and has recently emerged as a parameter for diastolic dysfunction and a prognostic marker after acute myocardial infarction. We aimed to assess the impact of CTO PCI on LACI in patients with ST-elevation myocardial infarction (STEMI) and concurrent CTO METHODS: In this CMR substudy of the multicentre randomised controlled EXPLORE trial, 200 patients (mean age 60 ± 10 years, 88% male) underwent baseline CMR, and 178 patients had analysable 4-month follow-up CMR. LACI was defined as the ratio of left atrial and left ventricular end-diastolic volumes. The primary outcome was the effect of CTO PCI on LACI and change of LACI over time RESULTS: The significant improvement in LACI over time (Δ LACI - 1.0% [Q1-Q3: - 4.6 to 2.0], P = 0.005) was independent of CTO PCI or no-CTO PCI (P = 0.706). CTO PCI did not influence the change in LACI (- 0.8% [Q1-Q3: - 4.7 to 2.2], P = 0.122). Baseline LACI ≥20.6% was associated with an increased risk of all-cause death compared to LACI <20.6% after multivariable adjustment (hazard ratio 2.37, 95% CI: 1.27 to 4.45, P = 0.007) CONCLUSIONS: Among STEMI patients with a concurrent CTO, CTO PCI did not affect LACI at 4 months or its improvement over time. Elevated LACI early after STEMI independently predicted long-term all-cause mortality Clinical trial registration: The Evaluating Xience and left ventricular function in PCI on occlusiOns afteR STEMI (EXPLORE) trial; NTR1108 www.trialregister.nl, Date registered NTR: 30-okt-2007.

Authors

Institutions

Publication Details

Journal
International Journal of Cardiology
Published
2026-01-08
DOI
https://doi.org/10.1016/j.ijcard.2026.134154
Primary Topic
Cardiovascular Function and Risk Factors
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Effect of percutaneous coronary intervention for chronic total occlusion on diastolic atrioventricular coupling in ST-elevation myocardial infarction patients

Bimmer E.P.M. Claessen, R Nijveldt, Paul Knaapen, Nick S. Nurmohamed et al.
International Journal of Cardiology
Cardiovascular Function and Risk Factors
article

Effect of percutaneous coronary intervention for chronic total occlusion on diastolic atrioventricular coupling in ST-elevation myocardial infarction patients

Bimmer E.P.M. Claessen, R Nijveldt, Paul Knaapen, Nick S. Nurmohamed, Ivo van Dongen, Casper F. Coerkamp, Mark Hinderks, J A Elias, René J. van der Schaaf, Truls Råmunddal, Alexander Hirsch, Peter Damman, R. Nils Planken, Loes P.C. Hoebers, Richard A.P. Takx, Erlend Eriksen, José P.S. Henriques
article en

Abstract

Percutaneous coronary intervention (PCI) for chronic total occlusion (CTO) did not improve left ventricular systolic function. The left atrioventricular coupling index (LACI), derived from cardiovascular magnetic resonance (CMR), reflects diastolic atrioventricular coupling and has recently emerged as a parameter for diastolic dysfunction and a prognostic marker after acute myocardial infarction. We aimed to assess the impact of CTO PCI on LACI in patients with ST-elevation myocardial infarction (STEMI) and concurrent CTO METHODS: In this CMR substudy of the multicentre randomised controlled EXPLORE trial, 200 patients (mean age 60 ± 10 years, 88% male) underwent baseline CMR, and 178 patients had analysable 4-month follow-up CMR. LACI was defined as the ratio of left atrial and left ventricular end-diastolic volumes. The primary outcome was the effect of CTO PCI on LACI and change of LACI over time RESULTS: The significant improvement in LACI over time (Δ LACI - 1.0% [Q1-Q3: - 4.6 to 2.0], P = 0.005) was independent of CTO PCI or no-CTO PCI (P = 0.706). CTO PCI did not influence the change in LACI (- 0.8% [Q1-Q3: - 4.7 to 2.2], P = 0.122). Baseline LACI ≥20.6% was associated with an increased risk of all-cause death compared to LACI <20.6% after multivariable adjustment (hazard ratio 2.37, 95% CI: 1.27 to 4.45, P = 0.007) CONCLUSIONS: Among STEMI patients with a concurrent CTO, CTO PCI did not affect LACI at 4 months or its improvement over time. Elevated LACI early after STEMI independently predicted long-term all-cause mortality Clinical trial registration: The Evaluating Xience and left ventricular function in PCI on occlusiOns afteR STEMI (EXPLORE) trial; NTR1108 www.trialregister.nl, Date registered NTR: 30-okt-2007.

International Journal of CardiologyVol. 448
Mayo Clinic (US), Radboud University Nijmegen (NL), Maastricht University Medical Centre (NL), Haukeland University Hospital (NO), Sahlgrenska University Hospital (SE), Radboud University Medical Center (NL), North Estonia Medical Centre (EE), OLVG (NL), Amsterdam Neuroscience (NL), Mayo Clinic in Florida (US), Amsterdam University Medical Centers (NL), University of Amsterdam (NL), Erasmus University Rotterdam (NL)
Amgen, AstraZeneca, Sanofi, Boston Scientific Corporation, Ultragenyx Pharmaceutical, Health~Holland, InfraRedx, Nipro, Abiomed, ZonMw, Abbott Vascular, Daiichi Sankyo Europe
Good health and well-being
Openalex Percentile: Top 94%
Cardiovascular Function and Risk Factors
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.